Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick S Laursen

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Antiviral Research|April 16, 2013
Broadly neutralizing antibodies against influenza virusesNick S Laursen, Ian A Wilson
Biomolecules|March 6, 2021
Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic StrategiesAlessandra Zarantonello, Henrik Pedersen, Nick S Laursen, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 13, 2021
Purification of Human Complement Component C4 and Sample Preparation for Structural Biology ApplicationsAlessandra Zarantonello, Sofia Mortensen, Nick S Laursen, et al.
The EMBO Journal|January 11, 2011
Substrate recognition by complement convertases revealed in the C5-cobra venom factor complexNick S Laursen, Kasper R Andersen, Ingke Braren, et al.
The Journal of Biological Chemistry|May 8, 2020
A C3-specific nanobody that blocks all three activation pathways in the human and murine complement systemHenrik Pedersen, Rasmus K Jensen, Annette G Hansen, et al.
Molecular Immunology|June 30, 2020
Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complementDennis V Pedersen, Thies Rösner, Annette G Hansen, et al.
Allergy|June 1, 2022
Nanobody-based human antibody formats act as IgE surrogate in hymenoptera venom allergyJosephine Baunvig Aagaard, Coline Sivelle, Michaela Fischer, et al.
Frontiers in Immunology|August 28, 2020
Functional and Structural Characterization of a Potent C1q Inhibitor Targeting the Classical Pathway of the Complement SystemNick S Laursen, Dennis V Pedersen, Heidi Gytz, et al.
The Journal of Biological Chemistry|February 5, 2023
Correction: A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complementRasmus K Jensen, Rasmus Pihl, Trine A F Gadeberg, et al.
The Journal of Biological Chemistry|March 3, 2018
A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complementRasmus K Jensen, Rasmus Pihl, Trine A F Gadeberg, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Antiviral Research|April 16, 2013
Broadly neutralizing antibodies against influenza virusesNick S Laursen, Ian A Wilson
Biomolecules|March 6, 2021
Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic StrategiesAlessandra Zarantonello, Henrik Pedersen, Nick S Laursen, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 13, 2021
Purification of Human Complement Component C4 and Sample Preparation for Structural Biology ApplicationsAlessandra Zarantonello, Sofia Mortensen, Nick S Laursen, et al.
The EMBO Journal|January 11, 2011
Substrate recognition by complement convertases revealed in the C5-cobra venom factor complexNick S Laursen, Kasper R Andersen, Ingke Braren, et al.
The Journal of Biological Chemistry|May 8, 2020
A C3-specific nanobody that blocks all three activation pathways in the human and murine complement systemHenrik Pedersen, Rasmus K Jensen, Annette G Hansen, et al.
Molecular Immunology|June 30, 2020
Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complementDennis V Pedersen, Thies Rösner, Annette G Hansen, et al.
Allergy|June 1, 2022
Nanobody-based human antibody formats act as IgE surrogate in hymenoptera venom allergyJosephine Baunvig Aagaard, Coline Sivelle, Michaela Fischer, et al.
Frontiers in Immunology|August 28, 2020
Functional and Structural Characterization of a Potent C1q Inhibitor Targeting the Classical Pathway of the Complement SystemNick S Laursen, Dennis V Pedersen, Heidi Gytz, et al.
The Journal of Biological Chemistry|February 5, 2023
Correction: A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complementRasmus K Jensen, Rasmus Pihl, Trine A F Gadeberg, et al.
The Journal of Biological Chemistry|March 3, 2018
A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complementRasmus K Jensen, Rasmus Pihl, Trine A F Gadeberg, et al.
Pageof 3